Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/York
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in York, PA

Studies commonly pay $75 to $4,500 per completed study

443 clinical trials are currently recruiting participants within 30 miles of York. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

443studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near York right now

Top 25 of 443 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cancer Care Associates of York — York, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion — Mechanicsburg, Pennsylvania (22.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Penn State Children's Hospital — Hershey, Pennsylvania (22.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Cancer Care Associates Of York ( Site 0174) — York, Pennsylvania (0.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
WellSpan Oncology Research — York, Pennsylvania (0.3 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — York, Pennsylvania (0.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Heart Failure Phase 2 Interventional 200 participants sought
Capital Area Research LLC — Camp Hill, Pennsylvania (21.4 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06979362)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Hershey, Pennsylvania (22.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Relapsed/Refractory Primary Central Nervous System Lymphoma Phase 3 Interventional 132 participants sought
Penn State Health Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Ono Pharmaceutical Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07104032)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (23.1 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis

Cholecystitis, Acute, Biliary Diseases N/A Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (0.3 mi) · Sponsor: WellSpan Health
See eligibility & contact on ClinicalTrials.gov (NCT07792200)

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Failed or Difficult Intubation, Sequela, Intubation; Difficult N/A Observational 150,000 participants sought
Children's Hospital - Penn State Hershey — Hershey, Pennsylvania (22.6 mi) · Sponsor: Children's Hospital of Philadelphia
See eligibility & contact on ClinicalTrials.gov (NCT02493478)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Steba Biotech S.A.
See eligibility & contact on ClinicalTrials.gov (NCT04620239)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
The Centers for Advanced Urology d/b/a Keystone Urology Specialist — Lancaster, Pennsylvania (23.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis With Cardiomyopathy Phase 3 Interventional 1,750 participants sought
Clinical Trial Site — Lancaster, Pennsylvania (23.1 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07052903)

A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)

Amyotrophic Lateral Sclerosis (ALS), Chronic Respiratory Failure Phase 2 Interventional 48 participants sought
Penn State Hershey ALS Clinic — Hershey, Pennsylvania (22.6 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT07071935)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (22.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Cystic Fibrosis N/A Observational 400 participants sought
Hershey Medical Center Pennsylvania State University — Hershey, Pennsylvania (22.6 mi) · Sponsor: Nicole Hamblett
See eligibility & contact on ClinicalTrials.gov (NCT06504589)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
WellSpan Heart and Vascular Research — York, Pennsylvania (0.3 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)
Actively enrolling

Studies you may be able to join near York

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in York

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Information Collection Enterprises

1501 Mt Rose Ave, York, PA 17403
(717) 650-6772

Presa Clinical Research, LLC.

100 Penn St Ste A, Hanover, PA 17331
(240) 385-4587

Capital Area Research LLC

★ 5.0
875 Poplar Church Rd #330, Camp Hill, PA 17011
(717) 963-8389
"The personalized care you receive here is beyond superb! Staff is easy to talk to, knowledgeable, and always on top of things. Highly recommend!"
— Donna Preas, 5★

Clinicaltrialmd.com

★ 5.0
2014 S Tollgate Rd Ste 207, Bel Air, MD 21015
(410) 670-3076
"Wonderful staff and easy testing. Overall, a good experience!"
— Julia, 5★

Cancer Care Associates of York

★ 4.8 (365 reviews)
25 Monument Rd suite 294, York, PA 17403
(717) 741-9229
"Dr O told me that there is no blood work available for cancer screening. That is not true. The american cancer society recommends the MCD/MCED tests …"
— Johnstown Johnny, 1★

Kingston Court Skilled Nursing and Rehabilitation Center

★ 4.0
2400 Kingston Ct, York, PA 17402
(717) 755-8811
"Went to visit, everyone was nice. Place looked clean, nice noise level was normal, people interacting with other people. Looked very organized and fr…"
— Guess Who, 5★

Select Physical Therapy - East York

★ 4.9
2860 Whiteford Rd, York, PA 17402
(717) 849-5485
"Select Physical Therapy in East York has been an excellent experience from start to finish. The entire team is friendly, compassionate, and truly att…"
— Myriam1790, 5★

Milan Laser Hair Removal

★ 5.0
3013 E Market St, York, PA 17406
(717) 741-3531
"After two appointments I saw AMAZING results! I felt so much better about putting my bathing suit on while on vacation. The nurses and front office s…"
— Amanda Klien, 5★

Innovo Detox

★ 4.2 (109 reviews)
7007 York Rd, Abbottstown, PA 17301
(717) 928-8776

Clinical trials in York: what's recruiting

The York area currently has 443 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to York, the most active research areas are:

  • Cancer & Oncology15 studies
  • Heart & Vascular3 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from York, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in York

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

York participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in York pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in York?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in York safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in York?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of York.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in York typically complete one or two studies per year.

Paid clinical trials near York

Other metros within reach

Harrisburg, PA400 Lancaster, PA424 Baltimore, MD1,652 Frederick, MD254 Reading, PA271 Hagerstown, MD107 Washington, DC2,362 Arlington, VA2,330

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in York Bladder Issues Due To Spinal Cord Injury in York All conditions

More of PA

Philadelphia2,171 Pittsburgh1,234 Lancaster424 Harrisburg400 Reading271 Allentown228 Scranton91 Erie88

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts